Delcath Enhances Board of Directors With Appointment of Commercial Leader, John R. Sylvester

NEXT STORY
Turning Point Therapeutics Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and Chief Financial Officer
PREV STORY
Plus Therapeutics, Inc. Announces Nasdaq Ticker Symbol Changes and Reverse Stock Split
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rising Health Concerns Is Expected To Drive In Vitro Diagnostics (IVD) Market Growth Till 2020: Grand View Research, Inc.

San Francisco, March 07, 2016 (GLOBE NEWSWIRE) -- Global in vitro diagnostics market is expected to ...

author_avatar
NASDAQ Market News

VBL Therapeutics Receives Milestone Payment From NanoCarrier Under Licensing Agreement for VB-111 in Japan

- Per agreement, milestone payments can exceed $100 million, in addition to double-digit million ...

author_avatar
NASDAQ Market News

GigaGen Publishes Research Describing Novel Mechanism of Action and Therapeutic Potential of its anti-CTLA-4 Drug Candidate, GIGA-564

author_avatar
NASDAQ Market News